U.S. Markets open in 34 hrs, 38 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,496.57 | 49.91 | 0.44% |
| NASDAQ | 2,282.78 | -29.52 | -1.28% |
| S&P 500 | 1,260.68 | 0.36 | 0.03% |
| Day Low 01:53 PM EDT | 73.91 | |
|---|---|---|
| Day High 09:30 AM EDT | 79.20 |
|
| Range | 5.29 | |
| Volume | 264,594 | |
| 30-Day Avg. Vol. | 109,000 |
|
| Difference | 142.75% | |
| Market Cap. | 2.2 B | |
| Change | -92.22 M | |
| Shares Out. | 28.98 M | |
| Percent Traded | 0.91% | |
| Revenue | 630.72 M | |
| Earnings | 55.96 M | |
| EPS (TTM) | 1.95001 |
| 52-Wk Low 8/20/07 | 42.51 | |
|---|---|---|
| 52-Wk High 7/18/08 | 79.20 |
|
| Range | 36.69 | |
| Prev. Close 7/17/08 | 78.71 | |
| Today's Open | 79.18 | |
| Change | 0.60% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 0.6628 | |
| P/E Ratio (TTM) | 37.40 | |
| P/E Ratio (Fwd.) | — |
By the time a new drug hits the market, it has passed through a series of clinical trials to make it safe and effective; guiding drugs through that process is what ICON does best. The contract research ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | 0.501 12/31/07 | 0.53 12/31/07 |
0.029
Beat
|
| Last Quarter | 0.532 3/31/08 | 0.56 3/31/08 |
0.028
Beat
|
| Quarterly - 12/31/2007 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 190.91 M | 630.72 M |
| Gross Profit | 79.16 M | 257.24 M |
| Operating Income | 20.91 M | 75.51 M |
| Net Income | 16.78 M | 55.96 M |
Real-Time Quote
